Radiation Oncology/Therapy: Page 53

ESTRO: APBI rivals WBI, with better cosmetic results
By AuntMinnieEurope.com staff writers
Accelerated partial-breast irradiation (APBI) with multicatheter interstitial brachytherapy is a safe and effective alternative to whole-breast irradiation (WBI) and has better cosmetic results, according to new research presented at the European Society for Radiotherapy and Oncology (ESTRO) conference.
May 3, 2016
ESTRO: Lung cancer radiotherapy linked to noncancer deaths
By AuntMinnieEurope.com staff writers
Treating patients who have early-stage non-small cell lung cancer with stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer, according to research presented at the European Society for Radiotherapy and Oncology (ESTRO) conference.
May 3, 2016
Elekta launches Monaco software update at ESTRO 35
By AuntMinnieEurope.com staff writers
Radiation oncology firm Elekta chose this week's European Society for Therapeutic Radiation & Oncology (ESTRO 35) meeting in Turin, Italy, to launch its latest version of its Monaco treatment planning software.
May 2, 2016
Mobius sets up shop in Europe
By AuntMinnieEurope.com staff writers
Radiation oncology software firm Mobius Medical Systems said it has established a European office in the Netherlands to better serve its customers and distribution partners in Europe, the Middle East, and Africa.
May 1, 2016
Genetic factors can affect patient sensitivity to radiotherapy
By AuntMinnieEurope.com staff writers
Some patients carry the form of a gene that makes them more sensitive to radiation therapy, researchers from the Université Paris-Saclay in France have found. The study has been published in the journal Oncotarget.
April 27, 2016
Elekta places MRI-guided linac in Amsterdam
By AuntMinnieEurope.com staff writers
Radiation oncology firm Elekta has installed an MRI-guided linear accelerator radiation therapy system at the Netherlands Cancer Institute (NKI) in Amsterdam.
April 20, 2016
Radiotherapy demand set to grow 16% by 2025
By Rebekah Moan
The demand for radiotherapy across all European countries will climb by an average of 16% between 2012 and 2025, with the highest increase expected for prostate cancer cases (24%), according to a new study published in Radiotherapy and Oncology.
April 18, 2016
Vision RT appoints new VP of global customer support
By AuntMinnieEurope.com staff writers
Radiation therapy software developer Vision RT has appointed a new vice president of global customer support.
April 5, 2016
Sirtex liver cancer treatment approved for NHS use
By AuntMinnieEurope.com staff writers
The U.K. National Institute for Health and Care Excellence has issued a brief stating that cancer treatment firm Sirtex Medical's SIR-Spheres Y-90 resin microspheres may be used by National Health Service (NHS) doctors to treat patients with inoperable primary liver cancer.
April 3, 2016
Elekta signs big deal with Australian firm
By AuntMinnieEurope.com staff writers
Radiation oncology firm Elekta and Australian radiotherapy provider GenesisCare have formed a partnership valued at more than 88 million euros.
April 3, 2016
IBA chosen for Belgium proton therapy center
By AuntMinnieEurope.com staff writers
Ion Beam Applications (IBA) said it has signed contracts with Belgium's University Hospitals Leuven and Katholieke Universiteit Leuven to install the country's first proton therapy center.
March 27, 2016
IBA reports strong 2015 numbers
By AuntMinnieEurope.com staff writers
Strong orders for proton therapy systems and linear accelerators helped Ion Beam Applications (IBA) achieve double-digit sales growth in 2015.
March 24, 2016
Previous Page
Page 53 of 129
Next Page